Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BNY Mellon Strategic Municipal Bond Fund Inc DSM

BNY Mellon Strategic Municipal Bond Fund, Inc. (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The Fund ordinarily invests all of its net assets in municipal obligations that provide income exempt from federal... see more

Recent & Breaking News (NYSE:DSM)

Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction; Global CDMO company combines DSM Pharmaceutical Products and Patheon

Globe Newswire November 19, 2013

Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction; Global CDMO company combines DSM Pharmaceutical Products and Patheon

Thomson Reuters ONE November 19, 2013

DSM - repurchase of shares (6-14 November 2013)

Globe Newswire November 15, 2013

DSM - repurchase of shares (6-14 November 2013)

Thomson Reuters ONE November 15, 2013

DSM Nutritional Products and HORN Animal Wellness Announce Partnership to Expand Pet Industry Reach

Business Wire November 14, 2013

DSM issues long-term EU300 mln bond

Globe Newswire November 6, 2013

DSM issues long-term Euro300 mln bond

Thomson Reuters ONE November 6, 2013

DSM announces repurchase of shares to cover existing option plans

Globe Newswire November 6, 2013

DSM announces repurchase of shares to cover existing option plans

Thomson Reuters ONE November 6, 2013

DSM maintains positive momentum in challenging markets

Globe Newswire November 5, 2013

DSM maintains positive momentum in challenging markets

Thomson Reuters ONE November 5, 2013

Dreyfus Strategic Municipal Bond Fund, Inc. (NYSE:DSM) Declares Dividend

Business Wire October 30, 2013

DSM Celebrates Opening of New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia

PR Newswire October 29, 2013

DSM and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease

PR Newswire October 29, 2013

Fund Statistics Now Available for: Dreyfus High Yield Strategies Fund, Dreyfus Municipal Income, Inc., Dreyfus Strategic Municipal Bond Fund, Inc., Dreyfus Strategic Municipals, Inc.

Business Wire October 29, 2013

DSM and Sanquin Sign Agreement for Commercial Manufacture of Factor IX - Antibody

PR Newswire October 24, 2013

ChromaDex Receives Strategic Investment From DSM Venturing

PR Newswire October 21, 2013

DSM completes acquisition of stake in Andre Pectin (China)

Globe Newswire October 9, 2013

DSM completes acquisition of stake in Andre Pectin (China)

Thomson Reuters ONE October 9, 2013

Dreyfus Strategic Municipal Bond Fund, Inc. (NYSE:DSM) Declares Dividend

Business Wire September 30, 2013